World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
29457
World Ranking
11358
National Ranking
615

Overview

Kai C. Wollert is affiliated with Hannover Medical School in Germany and has a primary research focus in medicine, particularly within cardiology and cardiovascular medicine. Their scholarly contributions span multiple interrelated fields including biochemistry, genetics, molecular biology, rheumatology, physiology, and hematology.

The research output of Kai C. Wollert encompasses investigations into significant cardiovascular topics such as cardiac fibrosis and remodeling, GDF15 and related biomarkers, signaling pathways implicated in disease, congenital heart defects research, nutrition and health in aging, macrophage migration inhibitory factor, and heart failure treatment and management.

Frequent publication venues for Wollert's work include:

  • Cardiovascular Research
  • Circulation
  • European Heart Journal
  • Nature Communications
  • Basic Research in Cardiology

Prominent recent papers authored or co-authored by Wollert include:

  • "Angiogenesis after acute myocardial infarction," 2020, Cardiovascular Research
  • "Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase," 2022, Science
  • "Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4," 2020, European Heart Journal
  • "Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis," 2022, European Heart Journal
  • "Skeletal muscle derived Musclin protects the heart during pathological overload," 2022, Nature Communications

Kai C. Wollert collaborates frequently with several researchers, including:

  • Johann Bauersachs
  • Mortimer Korf-Klingebiel
  • Tibor Kempf
  • Andreas Pich
  • Yong Wang

Best Publications

  • Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

    Kai C Wollert;Gerd P Meyer;Joachim Lotz;Stefanie Ringes Lichtenberg

  • Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

    Gerd P. Meyer;Kai C. Wollert;Joachim Lotz;Jan Steffens

  • Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium

    Michael Hofmann;Kai C. Wollert;Gerd P. Meyer;Alix Menke

  • The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury

    Tibor Kempf;Matthias Eden;Jens Strelau;Marian Naguib

  • GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

    Tibor Kempf;Alexander Zarbock;Christian Widera;Stefan Butz

  • Clinical applications of stem cells for the heart.

    Kai C. Wollert;Helmut Drexler

  • Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.

    Tibor Kempf;Stephan von Haehling;Stephan von Haehling;Timo Peter;Tim Allhoff

  • Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.

    Kai C Wollert;Tibor Kempf;Lars Wallentin

  • Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

    Thomas J. Wang;Kai C. Wollert;Martin G. Larson;Erin Coglianese

  • Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome.

    Christian Widera;Shashi K. Gupta;Johan M. Lorenzen;Claudia Bang

  • Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome

    Kai C. Wollert;Tibor Kempf;Timo Peter;Sylvia Olofsson

  • Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy ASSEMBLY OF SARCOMERIC UNITS IN SERIES VIA gp130/LEUKEMIA INHIBITORY FACTOR RECEPTOR-DEPENDENT PATHWAYS

    Kai C. Wollert;Tetsuya Taga;Mikiyoshi Saito;Masashi Narazaki

  • Signal Transducer and Activator of Transcription 3 Is Required for Myocardial Capillary Growth, Control of Interstitial Matrix Deposition, and Heart Protection From Ischemic Injury

    Denise Hilfiker-Kleiner;Andres Hilfiker;Martin Fuchs;Karol Kaminski

  • Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial

    Gerd P Meyer;Kai C Wollert;Joachim Lotz;Jens Pirr

  • Circulating Concentrations of Growth-Differentiation Factor 15 in Apparently Healthy Elderly Individuals and Patients with Chronic Heart Failure as Assessed by a New Immunoradiometric Sandwich Assay

    Tibor Kempf;Rüdiger Horn-Wichmann;Georg Brabant;Timo Peter

  • Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure. Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial

    Inder S. Anand;Tibor Kempf;Thomas S. Rector;Heike Tapken

  • Cell therapy for the treatment of coronary heart disease: a critical appraisal

    Kai C. Wollert;Helmut Drexler

  • Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.

    Beate Fiedler;Suzanne M. Lohmann;Albert Smolenski;Stephan Linnemüller

  • Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.

    Lars Lind;Lars Wallentin;Tibor Kempf;Heike Tapken

  • Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome

    Kai C. Wollert;Tibor Kempf;Bo Lagerqvist;Bertil Lindahl

Frequent Co-Authors

Helmut Drexler
Helmut Drexler Hanover University of Applied Sciences and Arts
Johann Bauersachs
Johann Bauersachs Hannover Medical School
Frank M. Bengel
Frank M. Bengel Hannover Medical School
Lars Wallentin
Lars Wallentin Uppsala University
Ramachandran S. Vasan
Ramachandran S. Vasan The University of Texas Health Science Center at San Antonio
Thomas J. Wang
Thomas J. Wang Vanderbilt University
Hugo A. Katus
Hugo A. Katus Heidelberg University
James L. Januzzi
James L. Januzzi Harvard University
Evangelos Giannitsis
Evangelos Giannitsis University Hospital Heidelberg
Bertil Lindahl
Bertil Lindahl Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

In addition to pursuing a medical degree in the USA, many students explore related healthcare pathways that offer flexible study options and strong job prospects. Online nursing programs, in particular, are growing in popularity thanks to their accessibility and affordability.

Aspiring nurse practitioners can find a range of cheap online fnp programs that let you continue working while earning advanced credentials. If you’re starting your nursing career or seeking to boost your qualifications, numerous affordable nursing programs online offer quality education at a lower cost.

For nurses interested in research or academic leadership, online nursing phd programs provide a pathway to higher-level roles and scholarly achievement. Those with an RN license can advance their careers by enrolling in programs focused on the average cost of rn to bsn programs, making it easier to upskill without a large financial burden.

Exploring these online degrees can open up diverse opportunities in healthcare, supporting various interests and career goals within the medical field.

Best Scientists Citing Kai C. Wollert

Trending Scientists

Recently Published Articles